GRANULES.NS Profit & Loss
Granules India Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹4,511.92 Cr. | ₹4,506.37 Cr. | ₹4,481.61 Cr. | ₹5,365.64 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹13.78 Cr. | ₹4.40 Cr. | ₹12.92 Cr. | ₹20.33 Cr. | OtherIncome |
| Total Income | ₹4,525.70 Cr. | ₹4,510.77 Cr. | ₹4,494.53 Cr. | ₹5,385.97 Cr. | Income |
| Cost of Materials Consumed | ₹2,352.65 Cr. | ₹2,208.22 Cr. | ₹1,724.94 Cr. | ₹2,099.78 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-45.37 Cr. | ₹-186.97 Cr. | ₹0.76 Cr. | ₹-224.08 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹472.23 Cr. | ₹597.86 Cr. | ₹659.80 Cr. | ₹888.36 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹55.93 Cr. | ₹105.82 Cr. | ₹103.24 Cr. | ₹114.35 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹184.49 Cr. | ₹207.33 Cr. | ₹225.50 Cr. | ₹296.14 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹818.58 Cr. | ₹1,031.28 Cr. | ₹1,150.87 Cr. | ₹1,416.44 Cr. | OtherExpenses |
| Total Expenses | ₹3,838.52 Cr. | ₹3,963.54 Cr. | ₹3,865.11 Cr. | ₹4,590.99 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹687.17 Cr. | ₹547.23 Cr. | ₹629.42 Cr. | ₹794.98 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹30.75 Cr. | ₹-10.00 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹687.17 Cr. | ₹547.23 Cr. | ₹660.17 Cr. | ₹784.98 Cr. | ProfitBeforeTax |
| Tax Expense | ₹170.58 Cr. | ₹141.92 Cr. | ₹158.65 Cr. | ₹189.96 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹516.60 Cr. | ₹405.31 Cr. | ₹501.52 Cr. | ₹595.02 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹516.60 Cr. | ₹425.81 Cr. | ₹501.52 Cr. | N/A | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹21.05 | ₹16.73 | ₹20.69 | ₹24.47 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹21.00 | ₹16.72 | ₹20.68 | ₹24.46 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from GRANULES.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).